Schonfeld Strategic Advisors’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-19,725
Closed -$197K 2737
2021
Q3
$197K Hold
19,725
﹤0.01% 1780
2021
Q2
$197K Sell
19,725
-20,000
-50% -$200K ﹤0.01% 1682
2021
Q1
$394K Buy
+39,725
New +$403K ﹤0.01% 1232

Other funds holding EQHA.U

Schonfeld Strategic Advisors's EQHA.U Position: Q4 2021 in Review

Schonfeld Strategic Advisors sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2021, closing a stake of 19,725 shares — an estimated $197K sold.

Schonfeld Strategic Advisors first reported a position in EQHA.U in Q1 2021 and held it in 3 quarters. The position peaked at $394K in Q1 2021. 23 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2021.

  • Schonfeld Strategic Advisors reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 19,725 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2021, an estimated $197K.
  • Schonfeld Strategic Advisors first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $394K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.